tirzepatide breast cancer study reduces growth in mouse , A mouse model found the anti-obesity medication tirzepatide slowed the growth of obesity-associated breast cancer. Amanda Kucinskas, BS, Highlighting 3 ongoing clinical trials
Pay in 4 interest-free payments of $7.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





















